A Bizarre Skin Disease Mysteriously Spreading In The UK
Monkeypox is a disease that I have been monitoring for quite a while now. It is not supposed to spread easily from human to human, and hopefully that is still true.
But human cases are now popping up in the UK, and authorities are not exactly sure how it is spreading. As we have seen with COVID, deadly diseases can mutate in dangerous and unpredictable ways. And as we have also seen, a handful of human cases can ultimately turn into a worldwide pandemic. So we should definitely keep an eye on this alarming new outbreak in the UK, because it could potentially become something much larger.
On Saturday, health authorities in the UK announced that two more human cases of monkeypox have been confirmed…
Two more cases of rare viral monkeypox infection have been diagnosed in England, health authorities said on Saturday, adding that they are not linked to one reported a week ago.
The UK Health Security Agency (UKHSA) said the latest infections involved people living in the same household and an investigation was underway into how they contracted the virus.
But these two new cases did not have any contact with the first case that was confirmed on May 7th.
So authorities are in a race to figure out how they could have contracted it.
As for the case that was confirmed on May 7th, authorities believe that the victim was infected in Nigeria…
It comes after the first case was detected in a person who recently flew into the UK from Nigeria on May 7.
The patient received specialist care in an isolation unit at Guy’s and St Thomas’ infectious disease hospital unit in London, according to the UK Health Security Agency (UKHSA).
Hopefully these cases have been isolated quickly enough and officials will be able to successfully contain these outbreaks.
Because monkeypox is not something that you want to mess around with.
It is similar to smallpox, but the good news is that it is usually not as severe. The following comes from the official CDC website…
In humans, the symptoms of monkeypox are similar to but milder than the symptoms of smallpox. Monkeypox begins with fever, headache, muscle aches, and exhaustion.
The main difference between symptoms of smallpox and monkeypox is that monkeypox causes lymph nodes to swell (lymphadenopathy) while smallpox does not.
The incubation period (time from infection to symptoms) for monkeypox is usually 7−14 days but can range from 5−21 days.
Since it has such a long incubation period, that would make it an ideal candidate for a global pandemic if it mutates into a form that can spread easily among humans.
According to the CDC, monkeypox has a death rate in humans of about 10 percent…
The illness typically lasts for 2−4 weeks. In Africa, monkeypox has been shown to cause death in as many as 1 in 10 persons who contract the disease.
COVID has a death rate of much less than 1 percent in humans, and it paralyzed the globe for two years.
So can you imagine what a pandemic with a death rate of about 10 percent would do?
Speaking of pandemics, the bird flu continues to spread like wildfire all across the United States.
Last week, a case was confirmed at a commercial facility in the state of Michigan for the very first time…
The state has found avian influenza at a commercial turkey farm in eastern Muskegon County, forcing the farm to kill its stock in an effort to prevent the virus from spreading.
While the state did not release the name of the farm, an employee at Sietsema Farms confirmed to News 8 it one of its facilities is involved.
This is the first confirmed case of bird flu at a commercial poultry operation in Michigan, the Michigan Department of Agriculture and Rural Development said.
There are still quite a few states that have completely escaped this plague so far, but in the states where it has hit the consequences have been absolutely devastating.
PBS is reporting that “over 37 million birds are dead across more than 30 states”, and since that figure is from earlier this month the true death toll is probably significantly higher by now.
Since early February, we have gone from one confirmed case at a commercial facility in the U.S. to more than 37 million dead.
That is scary.
And a few weeks ago, the CDC confirmed a human case of the bird flu in Colorado…
A person has tested positive for avian influenza A(H5) virus (H5 bird flu) in the U.S., as reported by Colorado and confirmed by CDC. This case occurred in a person who had direct exposure to poultry and was involved in the culling (depopulating) of poultry with presumptive H5N1 bird flu.
The patient reported fatigue for a few days as their only symptom and has since recovered. The patient is being isolated and treated with the influenza antiviral drug oseltamivir.
While it is possible the detection of H5 bird flu in this specimen is a result of surface contamination of the nasal membrane, that can’t be determined at this point and the positive test result meets the criteria for an H5 case. The appropriate public health response at this time is to assume this is an infection and take actions to contain and treat.
The CDC says that the death rate for the bird flu in humans can be as high as 60 percent.
So we better hope that the bird flu never mutates into a form that can spread easily among humans.
If you follow my work on a regular basis, then you already know that I believe that we have entered an era of great pestilences.
All over the globe, curious scientists are monkeying around with extremely deadly diseases, and as we have seen it is way too easy for deadly diseases to escape from a lab environment.
We are tempting fate every single day, and at some point our luck will run out.
Hopefully it will not be tomorrow, but without a doubt a day of reckoning is fast approaching.
See more here: endoftheamericandream.com
Header image: Wallpaper Safari
Editor’s note: I looked up Monkeypox and it seems it was unknown in the UK before 2018, when there were two cases, and has not been seen since before now, when there are apparently now 20 cases. The gov.uk website says “the virus does not usually spread easily between people and the risk to the UK population remains low.” It also states “A notable proportion of early cases detected have been in gay and bisexual men.”
Please Donate Below To Support Our Ongoing Work To Defend The Scientific Method
PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company 
incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX.
Trackback from your site.
Howdy
| #
Scaremongering to ‘drum up’ interest.
Reply
Ogmios
| #
Lots of people played the stupid game and won a stupid prize, shingles. How many could tell the difference in symptoms between that and monkeypox? Just a thought.
Reply
jessia noria
| #
I make 85 dollars each hour for working an online job at home. dso I never thought I can do it but my best friend makes 10000 bucks every month working this job and she recommended me to learn more about it.
The potential with this is endless…>>>>>>https://t.ly/eGAt
Reply
JFK
| #
Even easier if they release them on purpose…
That “great reset” won’t bring itself into existence without help…
Reply
TheQuieterOne
| #
Not a real disease. Cases are headaches plus positive tests. Are we REALLY going to fall for this bloody routine again?
“Can you imagine what a pandemic with a death rate of about 10 percent would do?” Piss off, Neil!
Reply
bmatkin
| #
I’ve read somewhere that Wuhan was working on Monkey pox. I wonder if Fauci has a patent on some killer vaccine for this disease????
Reply
Richard Noakes
| #
EXC: The Infamous Wuhan Lab Recently Assembled Monkeypox Strains Using Methods Flagged For Creating ‘Contagious Pathogens’.
Are we here because of China’s experiments again?
by Natalie Winters May 22, 2022
The Wuhan Institute of Virology assembled a monkeypox virus genome, allowing the virus to be identified through PCR tests, using a method researchers flagged for potentially creating a “contagious pathogen,” The National Pulse can reveal.
Support our important research by clicking here.
The study was first published in February 2022, just months before the latest international outbreak of monkeypox cases which appear to have now reached the United States.
The paper, which was authored by nine Wuhan Institute of Virology researchers and published in the lab’s quarterly scientific journal Virologica Sinica, also follows the wide-scale use of Polymerase Chain Reaction (PCR) tests to identify COVID-19-positive individuals.
Researchers appeared to identify a portion of the monkeypox virus genome, enabling PCR tests to identify the virus, in the paper: “Efficient Assembly of a Large Fragment of Monkeypox Virus Genome as a qPCR Template Using Dual-Selection Based Transformation-Associated Recombination.”
Monkey pox viruses – referred to as “MPXVs” in the paper – have strains that are “more pathogenic and [have] been reported to infect humans in various parts of the world.”
“Quantitative polymerase chain reaction (qPCR) is the gold standard for the detection of orthopoxvirus (including MPXV). For pan-orthopoxviruses detection, the E9L (DNA polymerase) gene has been shown to be an excellent target for qPCR assays. For MPXV detection, Li et al. reported that the C3L (complement-binding protein) gene could be used as the qPCR target for the MPXV Congo Basin strain,” explained the paper before noting that China lacked sufficient genetic information on the virus for PCR detection:
“Since MPXV infection has never been associated with an outbreak in China, the viral genomic material required for qPCR detection is unavailable. In this report, we employed dual-selective TAR to assemble a 55-kb MPXV genomic fragment that encompasses E9L and C3L, two valuable qPCR targets for detecting MPXV or other orthopoxviruses.”
“The primary purpose of assembling a fragment of the MPXV genome is to provide a nucleotide template for MPXV detection,” reiterated the study, which relied on the process of transformation-associated recombination (TAR) to isolate a genomic fragment of the monkeypox virus.
MUST READ: Wuhan Lab Publishes Study Manipulating H7N9 Virus To Be More Lethal.
“As an efficient tool for assembling large DNA fragments up to 592 kb in length, TAR assembly has become essential for preparing infectious clones of large DNA/RNA viruses,” explained researchers.
The paper acknowledged that TAR “applied in virological research could also raise potential security concerns, especially when the assembled product contains a full set of genetic material that can be recovered into a contagious pathogen.”
“In this study, although a full-length viral genome would be the ideal reference template for detecting MPXV by qPCR, we only sought to assemble a 55-kb viral fragment, less than one-third of the MPXV genome. This assembly product is fail-safe by virtually eliminating any risk of recovering into an infectious virus while providing multiple qPCR targets for detecting MPXV or other Orthopoxviruses,” posited researchers.
The unearthed study follows the Wuhan Institue of Virology conducting similar research into strains of bat coronaviruses that could infect humans while admitting its facilities lacked proper laboratory safety protocols.
Read: https://www.scribd.com/document/575186014/1-s2-0-S1995820X22000414-main#download&from_embed
The National Pulse
Reply
Richard Noakes
| #
Biden Sounds Alarm on Monkeypox as CDC Alerts American Doctors
By Jack Phillips May 22, 2022 Updated: May 23, 2022 0:003:52
President Joe Biden claimed Sunday that “everybody” should be concerned about an increase of monkeypox cases in Europe and the United States, although the president admitted that he hasn’t received information from his advisers on the disease yet.
Speaking to reporters before leaving for Japan and South Korea, Biden said that his health advisers “haven’t told me the level of exposure yet, but it is something that everybody should be concerned about,” adding, “We’re working on it hard to figure out what we do and what vaccine, if any, may be available for it.”
“But it is a concern in the sense that if it were to spread, it’s consequential. That’s all they have told me,” Biden continued.
As of May 21, more than 80 cases of monkeypox have been reported in Australia, the United States, Canada, and Europe. In a statement the day before, the World Health Organization (WHO) said it is working to investigate another 50 suspected cases, warning that more could be reported in the near future.
“WHO is working with the affected countries and others to expand disease surveillance to find and support people who may be affected, and to provide guidance on how to manage the disease,” the WHO said in a statement on Friday.
Also on Sunday, White House national security adviser Jake Sullivan told reporters that the United States has vaccines “relevant to treating monkeypox,” although he did not elaborate.
Monkeypox is mostly reported in Central and West Africa, where hundreds of cases have been reported on a yearly basis. The monkeypox virus was first reported in laboratory monkeys in 1958, and the first human cases were found in the Democratic Republic of the Congo in the early 1970s.
A 1971 photo from the Centers for Disease Control handout shows monkeypox-like lesions on the arm and leg of a female child in Bondua, Liberia. (CDC/Getty Images)
But most of the recent cases elsewhere appear to have no connection with Africa.
Symptoms of monkeypox—which is related to the smallpox virus—include fever, body aches, and rashes. Smallpox, which has been responsible for a number of pandemics throughout history, presents more severe symptoms.
With the world on heightened alert over COVID-19, the WHO noted that monkeypox spreads differently and namely through close contact with an infected animal or person. UK health officials warned that homosexual men appear to be at most risk of contracting the disease.
Neil Mabbott, a disease expert at the University of Edinburgh, told The Associated Press on May 21 that recent cases suggest a potential new means of contracting the virus: sexual transmission. And Keith Neal, an infectious disease epidemiologist at the University of Nottingham, told the outlet that the mode of transmission may not be via sexual activity but instead may be through “the close contact associated with sexual intercourse.”
The Centers for Disease Control and Prevention (CDC) has warned that sexually transmitted diseases among homosexual males have been on the rise in recent years. In 2014, that group accounted for about 83 percent of syphilis, a type of sexually transmitted bacterial infection, in the United States.
The CDC said in a recent update that regarding cases reported in the United Kingdom, there was a “temporally clustered group of cases involving four people.”
“Some evidence suggests that cases among [homosexual males] may be epidemiologically linked; the patients in this cluster were identified at sexual health clinics,” the agency stated. “This is an evolving investigation and public health authorities hope to learn more about routes of exposure in the coming days.”
The Epoch Times
Reply
Richard Noakes
| #
US Buys $119 Million Monkeypox Vaccines Following Pandemic Simulation
May 21, 2022
A report has warned of a new pandemic warning after 250 million people died of a genetically modified strain of monkeypox in a war game simulation similar to Event-201 conducted just before COVID-19 hit the world. Following the simulation, the US is buying $119 million monkeypox vaccines.
BIG STORY: Genetically Modified Strain Of Monkeypox Kills 250 Million People In War Game Simulation Prompting New Pandemic Warning
After the first incidence of monkeypox in the United States this year was verified in Massachusetts on May 18, the Biden government made a purchase for millions of doses of a vaccine that protects against smallpox and monkeypox.
Since the start of May, monkeypox, a viral illness generally confined to Africa, has been recorded in many countries, with more than 25 reported cases.
Bavarian Nordic, a Danish biotech business, received the order on May 18, prompting the company to transform its bulk liquid smallpox vaccine into freeze-dried versions with a longer shelf life.
According to Bavarian Nordic, the bulk vaccination has already been made and invoiced under previous contracts with the US government. In the United States, the vaccination is referred to as “JYNNEOS.”
Jynneos vaccines worth $119 million will be produced and billed in 2023 and 2024, according to the order.
The Biden administration has the opportunity to lodge another $180 million order under the deal. By 2024 and 2025, around 13 million freeze-dried dosages of the Jynneos smallpox vaccine would be available. According to the firm, the majority of the bulk vaccine for those dosages has already been produced and invoiced.
Bavarian Nordic later declared on May 19 that it will supply its smallpox vaccine to “an undisclosed European country.” It is approved for smallpox in Europe under the brand name “IMVANEX,” although the company claims it was previously used off-label for monkeypox.
The company’s Jynneos vaccine was authorized by the US Food and Drug Administration (FDA) in September 2019 for the treatment of smallpox and monkeypox illness in people aged 18 and up. The vaccine would be “available for those determined to be at high risk of either smallpox or monkeypox infection.”
“This is the only currently FDA-approved vaccine for the prevention of monkeypox disease,” the FDA said at the time.
Smallpox, a highly contagious virus, “could have a devastating effect” upon “the intentional release,” stated Peter Marks, head of the FDA’s Center for Biologics Evaluation and Research, at the time.
The present monkeypox scenario in Europe, according to Bavarian Nordic President and CEO Paul Chaplin, “calls for a rapid and coordinated approach by the health authorities,” and the company is “pleased to assist in this emergency situation.”
In 2004, the National Institute of Allergy and Infectious Diseases (NIAID) awarded Barvarian Nordic a $100 million contract (read below) as part of Project BioShield, a government initiative to encourage private businesses to create vaccines and other mitigation strategies to deal with chemical, biological, radiological, and nuclear threats.
Growing Cases of Monkeypox
Monkeypox in people has symptoms that are comparable to smallpox but are milder, according to the Centers for Disease Control and Prevention. Fever, headache, muscle aches, and fatigue are common symptoms, as are skin lesions that can persist up to a month.
Following the onset of a fever, patients may develop a rash that begins on the face and progresses to other regions of the body. According to the CDC, monkeypox induces lymph node swelling whereas smallpox does not.
Authorities in a number of nations have reported that the great majority of cases involve men having intercourse with other men, but they have yet to verify how people become infected. Monkeypox “can be transmitted by droplet exposure via exhaled large droplets and by contact with infected skin lesions or contaminated materials,” according to the World Health Organization.
On May 20, Italy, Sweden, and Australia each announced their initial confirmed monkeypox cases of the year.
On May 19, Canada confirmed the first two cases in Quebec, and 17 suspected cases are being investigated in the broader Montreal area.
On May 18, the United States reported one case in Massachusetts. In New York City, a probable case of monkeypox is being examined after a man appeared with signs on May 19.
On May 19 itself, Spain identified seven cases, while Portugal reported 14 confirmed cases. Over 40 cases of monkeypox have been reported in Spain and Portugal. France confirmed its first probable case in the Paris/Ile-de-France region on the same day.
In the United Kingdom, where the first cases outside of Africa were recorded, there are nine confirmed monkeypox cases. On May 7, the first case in the United Kingdom was recorded, involving a patient who had recently gone to Nigeria.
Experts have recently raised concerns about the growing dangers posed by the production of deadly diseases in laboratories, which could be unleashed into the wild either accidentally or deliberately by unscrupulous actors.
Meanwhile, a report has warned of a new pandemic warning after 250 million people died of a genetically modified strain of monkeypox in a war game simulation similar to Event-201 conducted just before COVID-19 hit the world.
GreatGameIndia
Reply
Mark Tapley
| #
Hello Noakes:
It is amazing to me that in the midst of the covid fake virus medical fraud verified by a fake test that has induced millions of idiots to be injured and killed by another blood toxin injection, there are still people like you that suck up any crap that is thrown out by the Zionist controlled medical cartel and big Pharma mafia. Not a new variant of the fake virus but now monkey pox. Richard I hope you run out and get a dose of this tissue sample garbage as soon as possible. I believe these criminals that control all the countries which had their fake PCR tests ordered in 2018 long before the fake covid was sprang are actually testing the public to see just how stupid they are. Noakes, you are leading the pack of fake virus idiots in the germ theory pathogenic stupidity contest.
Reply
Wisenox
| #
If the pox outbreak is real, then the probability that its natural is zero at best. Two problems arise with the official narrative. 1. We aren’t shown pictures of the patients. We are shown pictures of monkeypox, and those are likely from a medical textbook. 2. The vaccination status of infected individuals is left out.
Considering the statistical impossibility of a second pandemic in 2 years, it is essential to include the possibility that the vaccines play a role.
So, let’s consider:
The Moderna patent includes DEFA in its lengthy table, which could account for the symptoms. DEFA, sequence ID 2139, is associated with Bell’s Palsy, which is related to Chickenpox and Herpes Zoster and presents with herpes-like sores.
A second consideration is the reactivation of latent zoster viruses in the neural ganglia. The study “The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting” states:
“After primary infection, VZV remains latent in neural ganglia until potential reactivation.”
https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-019-3759-z
This begs the question, does the vaccine affect the neural ganglia? Yes.
The Moderna patent includes the ability to cross the blood brain barrier and central nervous system:
2015/0030576: METHODS AND COMPOSITIONS FOR TARGETING AGENTS INTO AND ACROSS THE BLOOD-BRAIN BARRIER.
This absolutely has the potential to reactivate latent zoster viruses, but it goes unmentioned. Is that peculiar, or expected?
Additionally, the above technology suggests using Theiler’s Encephalomyelovirus and Encephalomyocarditis Virus, both picornaviruses, as vehicles to cross the barrier. Could they be the cause of myocarditis side effects from the vaccine?
Are they crossing the blood brain barrier?
Patent:
https://pubchem.ncbi.nlm.nih.gov/patent/US-10703789-B2#section=Full-Text
Reply